Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal oxytocin for sexual dysfunction in lactating women
IRCT20120718010324N55Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised trial in female sexual dysfunction (FSD) comparing Oxytocin gel with Placebo gel (2 arms). Primary endpoint: Sexual function. Started May 2020; status: completed.
02
Drugs
oxytocin
03
Conditions
female sexual dysfunction (FSD)
Beyond the preview
Go deeper on IRCT20120718010324N55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120718010324N55.